Olaptesed pegol, an anti-CXCL12|[sol]|SDF-1 Spiegelmer, alone and with bortezomib|[ndash]|dexamethasone in relapsed|[sol]|refractory multiple myeloma: a Phase IIa Study

2017

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib–dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

16

References

41

Citations